Modulation of phospholipid methylation in rabbit leukocytes by indomethacin
- PMID: 3007356
- DOI: 10.1007/BF00916042
Modulation of phospholipid methylation in rabbit leukocytes by indomethacin
Abstract
Methylation of membrane phospholipids has been implicated as an early biochemical signal for the chemotactic migration of phagocytic cells into inflammatory sites. In this study, the ability of indomethacin to modulate phospholipid methylation as one of its mechanisms of antiinflammatory action was investigated. Nontoxic doses of indomethacin (10(-4) M and 10(-5) M) were found to retard the methylation of phosphatidylmonomethylethanolamine (PMME) to phosphatidyldimethylethanolamine (PDME) and phosphatidylcholine (PC) in rabbit leukocytes, suggesting inhibition of methyltransferase II activity. Indomethacin was, however, without effect on the uptake of L-[methyl 3H]methionine by rabbit leukocytes. It is suggested that the inhibition of membrane phospholipid methylation could result in the suppression of inflammatory responses such as prostaglandin and leukotriene synthesis, generation of reactive oxygen radicals, and chemotaxis.
Similar articles
-
Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.Biochem Pharmacol. 1988 May 1;37(9):1693-8. doi: 10.1016/0006-2952(88)90430-3. Biochem Pharmacol. 1988. PMID: 2837237
-
Effect of modification of membrane phospholipid composition on phospholipid methylation in aggregating cell culture.J Neurochem. 1986 Jun;46(6):1859-64. doi: 10.1111/j.1471-4159.1986.tb08505.x. J Neurochem. 1986. PMID: 3701334
-
Kinetic mechanism of phosphatidylethanolamine N-methyltransferase.J Biol Chem. 1988 Nov 15;263(32):16864-71. J Biol Chem. 1988. PMID: 3182819
-
[Phospholipid transmethylation of the membrane in human neutrophils and lymphocytes].Arerugi. 1984 Apr;33(4):207-15. Arerugi. 1984. PMID: 6477133 Japanese. No abstract available.
-
Receptors for chemotactic formyl peptides as pharmacological targets.Int Immunopharmacol. 2002 Jan;2(1):1-13. doi: 10.1016/s1567-5769(01)00150-3. Int Immunopharmacol. 2002. PMID: 11789660 Review.